| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5900157 | Diabetes Research and Clinical Practice | 2011 | 4 Pages |
Abstract
Rapid improvement in glycaemic control induced by GLP-1 agonist therapy could be yet another illustration of transient or permanent progression of diabetic retinopathy, similar to documented examples such as pregnancy and continuous subcutaneous insulin infusion. Specific guidelines would be needed to monitor this paradoxical phenomenon during treatment with GLP-1 agonists.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Lakshminarayanan Varadhan, Tracy Humphreys, Christian Hariman, Adrian B. Walker, George I. Varughese,